FBRX: Forte Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 38.36
Enterprise Value ($M) 22.00
Book Value ($M) 9.37
Book Value / Share 1.46
Price / Book 4.10
NCAV ($M) 9.09
NCAV / Share 1.42
Price / NCAV 4.22

Profitability (mra)
Return on Invested Capital (ROIC) -3.65
Return on Assets (ROA) -0.88
Return on Equity (ROE) -0.97

Liquidity (mrq)
Quick Ratio 2.06
Current Ratio 2.06

Balance Sheet (mrq) ($M)
Current Assets 17.67
Assets 17.95
Liabilities 8.58
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Orbimed Advisors Llc 8.00
02-14 13G Ikarian Capital, LLC 9.50
02-14 13G/A Alger Associates Inc 17.70 18.25
02-14 13G/A Tybourne Capital Management (hk) Ltd 9.99 -82.35
02-14 13G Janus Henderson Group Plc 10.00
02-14 13G/A Biotechnology Value Fund L P 9.99 -78.42
02-14 13G/A Perceptive Advisors Llc 2.50 8.26
02-13 13G Boothbay Fund Management, Llc 6.00
01-10 13G Oliveira Steven Michael 6.76
06-17 13D/A Camac Fund, LP 4.00 -7.30
2024-02-14 13G/A Farallon Capital Partners, L.P. 9.90 0.15

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-29 10-K/A Powers of Attorney (contained in the signature page to this Annual Report on Form 10-K).
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 5,785 38,916 14.87
2025-03-13 3,573 18,672 19.14
2025-03-12 6,160 42,364 14.54
2025-03-11 2,292 15,332 14.95
2025-03-10 3,968 13,234 29.98

(click for more detail)

Similar Companies
EVOK – Evoke Pharma, Inc. EYEN – Eyenovia, Inc.
FBIO – Fortress Biotech, Inc. FENC – Fennec Pharmaceuticals Inc.
FLGC – Flora Growth Corp.


Financial data and stock pages provided by
Fintel.io